Mr Mrs Miss Ms Dr Other

Ms
Punita
Shah

Patent Director

Manchester Office

Life sciences

Telephone. +44(0) 161 247 4900
Mobile. +44(0) 796 854 3578
Email. [email protected]

Experience

Punita's expertise lies predominantly in the area of biotechnology, with a specific focus on the technical fields of Agbio, diagnostics including point of care lateral flow tests, personalized medicine, biologics and gene therapy. Her experience also includes leading multi-disciplinary teams handling innovations which span the life sciences and electronics sectors. At both a personal and professional level, Punita is keenly interested in sustainable technology, in particular the ways in which the life sciences sector can improve sustainability to address key problems such as plastic pollution, packaging and the food industry.

Punita has worked extensively with multinational corporations, universities, and small to medium sized enterprises. She has a practical and commercially focused approach, and over the course of her career has assisted numerous small companies with IP portfolio management, with a focus toward building a robust patent strategy.

Punita is highly experienced in obtaining commercially valuable patent protection for her clients. Her practice includes routinely managing large global patent portfolios, as well as conducting due diligence to support corporate acquisition and investment, conducting freedom to operate analysis, and advising her clients on third party rights and infringement. Punita has defended her clients patent rights and commercial position in leading opposition and appeal proceedings before the EPO.

Qualifications

Patent Attorney

Chartered (UK)
Europe


MA

MA (Cantab) Natural Sciences

Publications

Healthcare and Climate Change

View publication online

Conferences: 2020

November 16th 2020

CIPA Life Sciences conference 2020

Attended

Related News

New Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article
Event - 16th November 2023

Webinar in cooperation with the BVIZ: Licensing and Technology Transfer

HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …

Event details

Investing in Patents for Space Tech: Safeguarding Innovations in the Space Sector

The advent of commercial launch capabilities has opened up space as a unique frontier for innovation. However, in space, any acts of patent infringement almost always go unseen. Thus, it’s …

Read article

End of EPO "10 day rule" from 1 November 2023 – 4 weeks to go

Any communications sent from the EPO on or after 1 November 2023 will no longer have the “ten day rule” applied to them.   This means that communications are deemed to …

Read article
Event - 21st, 28th November 2023

Dresden & Salzburg Seminar: Licensing and Technology Transfer

HGF is pleased to invite you to our upcoming German-language seminar on “In- and Out-licensing of Technologies” in Salzburg and Dresden. The seminar will offer you the opportunity to gain …

Event details
Event - 26th September 2023

Bioforward OBN Conference 2023

Bioforward, OBN’s ‘Roadmap for Growth’ Life Sciences event is set to take place at The King’s Centre in Oxford on Tuesday 26th September 2023. This event is designed to provide the support, skills, know-how …

Event details

AI-Powered Personalised Medicine

The integration of artificial intelligence (AI) into healthcare has ushered in a new era of personalised medicine, promising more effective and tailored treatments for patients. Traditional medical approaches often adopt …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.